Levocetirizine Dihydrochloride Tablet, Film Coated
Product Images NDC 0093-7701

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 0093-7701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levocetirizine Dihydrochloride Structural Formula (Image 1)

Chemical structure of Levocetirizine Dihydrochloride showing the molecular arrangement with chlorine-substituted aromatic rings, a piperazine ring, and associated hydrochloride ions (2HCl). This structure represents the active ingredient Levocetirizine Dihydrochloride.*

FDA Label Image

Image (Image 2)

Label for Levocetirizine Dihydrochloride Tablets USP 5 mg by Teva Pharmaceuticals USA, Inc. The label shows a bottle containing 90 film-coated oral tablets. It includes the NDC number 0093-7701-98 and usage notes such as prescription only and child-resistant packaging information. The label features teal and yellow highlighted text with the Teva logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.